A carregar...

Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors

PURPOSE OF REVIEW: With the advent of cancer immunotherapy and immune checkpoint inhibitors, patients with malignancies can now achieve durable remissions for conditions previously described as terminal. However, immune-related adverse events (irAEs) associated with cancer immunotherapy have become...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Rheumatol Rep
Main Authors: Sandigursky, Sabina, Mor, Adam
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6488223/
https://ncbi.nlm.nih.gov/pubmed/30191417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11926-018-0770-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!